TPR Activators
TPR activators encompass a diverse array of compounds that intricately modulate the activation of the target protein, TPR, employing both direct and indirect mechanisms. These chemicals, each distinguished by a unique mode of action, play pivotal roles in cellular processes associated with TPR activity. One prominent indirect activator within this category is Resveratrol, a polyphenol abundantly found in red grapes. Resveratrol acts by influencing the SIRT1 pathway, enhancing TPR activation through a sophisticated interplay of molecular events. Specifically, Resveratrol augments SIRT1 deacetylase activity, orchestrating chromatin remodeling and transcriptional regulation. This intricate process ultimately fosters TPR participation in diverse cellular functions.
Another noteworthy member of the TPR activators is Forskolin, which operates through an indirect mechanism. Forskolin stimulates adenylate cyclase, leading to an increase in cyclic adenosine monophosphate (cAMP) levels. The elevated cAMP levels subsequently activate protein kinase A (PKA), initiating a cascade of events that culminate in the phosphorylation and activation of TPR. The intricate signaling pathways triggered by Forskolin establish a crucial link between cAMP-dependent signaling and TPR activation, influencing various cellular responses. These examples underscore the complexity of the network of signaling pathways and molecular interactions through which TPR activators exert their effects, providing nuanced and precise control over TPR-mediated cellular processes. In summary, TPR activators form a diverse and sophisticated group of compounds that regulate TPR activation through intricate mechanisms. The examples of Resveratrol and Forskolin highlight the multifaceted nature of these activators, showcasing their ability to modulate TPR activity indirectly by influencing crucial cellular pathways.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a polyphenol found in red grapes, activates TPR indirectly by modulating the SIRT1 pathway. It enhances SIRT1 deacetylase activity, leading to deacetylation and activation of TPR. This activation occurs through downstream effects on chromatin remodeling and transcriptional regulation, promoting TPR's participation in cellular processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates TPR indirectly by stimulating adenylate cyclase, resulting in elevated cAMP levels. Increased cAMP activates PKA, which in turn phosphorylates and activates TPR. This cascade influences cellular responses mediated by TPR, linking forskolin-induced signaling to TPR activation and subsequent cellular processes. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin, a flavonoid, indirectly activates TPR by inhibiting histone deacetylases (HDACs). HDAC inhibition leads to altered chromatin structure, facilitating TPR expression and activation. This epigenetic modulation contributes to the regulation of TPR-associated pathways and cellular functions, establishing quercetin as an indirect activator of TPR. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 indirectly activates TPR by inhibiting NF-κB signaling. The compound suppresses NF-κB activation, reducing its inhibitory effect on TPR. This interference enhances TPR expression and activity, connecting BAY 11-7082 to the modulation of TPR-associated cellular processes through NF-κB-dependent pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632, a Rho-associated protein kinase (ROCK) inhibitor, indirectly activates TPR by influencing actin cytoskeleton dynamics. Inhibition of ROCK by Y-27632 leads to cytoskeletal rearrangements that impact TPR localization and activation. This indirect activation links Y-27632 to the regulation of TPR-associated cellular functions mediated by actin dynamics. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662 indirectly activates TPR through AMP-activated protein kinase (AMPK) activation. The compound activates AMPK, which phosphorylates and activates TPR. This AMPK-mediated activation connects A769662 to the modulation of TPR-associated cellular processes, highlighting its role in the regulation of energy homeostasis and related signaling pathways. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine indirectly activates TPR by influencing DNA methylation patterns. As a demethylating agent, it promotes the demethylation of CpG islands within the TPR promoter region, leading to increased TPR expression and activation. This epigenetic modification establishes 5-Azacytidine as an indirect activator of TPR, impacting cellular processes associated with TPR activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB-203580 indirectly activates TPR by inhibiting p38 mitogen-activated protein kinase (MAPK). Inhibition of p38 MAPK by SB-203580 relieves its suppressive effect on TPR, leading to increased TPR activity. This modulation connects SB-203580 to the regulation of TPR-associated cellular processes mediated by the p38 MAPK signaling pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 indirectly activates TPR through the inhibition of phosphoinositide 3-kinase (PI3K). Inhibition of PI3K by LY294002 disrupts downstream signaling, resulting in enhanced TPR activity. This PI3K-dependent modulation establishes LY294002 as an indirect activator of TPR, influencing cellular processes associated with TPR activation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A indirectly activates TPR by inhibiting histone deacetylases (HDACs). HDAC inhibition by Trichostatin A leads to altered chromatin structure, facilitating TPR expression and activation. This epigenetic modulation connects Trichostatin A to the regulation of TPR-associated pathways and cellular functions, establishing it as an indirect activator of TPR. | ||||||